Contact
searchSearch
HMP Global

July 2012 - FRMC

Tamoxifen Therapy for 10 Years versus 5 Years
07/22/2013
Tim Casey
  Chicago—Patients who took tamoxifen for 10 years had a reduced disease recurrence and breast cancer mortality compared with a group receiving the drug for 5 years, according to a randomized, phase 3 trial that began >20 years ago. The...
  Chicago—Patients who took tamoxifen for 10 years had a reduced disease recurrence and breast cancer mortality compared with a group receiving the drug for 5 years, according to a randomized, phase 3 trial that began >20 years ago. The...
  Chicago—Patients who took...
07/22/2013
First Report Managed Care
Novel Monoclonal Antibody to PCSK9
07/23/2012
Kevin L. Carter
Studies of animal models have found that proprotein convertase subtilisin/kexin 9 (PCSK9), one of the serine proteases, has a role in the post-translational regulation of LDL-receptor activity. PCSK9, which is synthesized primarily in the...
Studies of animal models have found that proprotein convertase subtilisin/kexin 9 (PCSK9), one of the serine proteases, has a role in the post-translational regulation of LDL-receptor activity. PCSK9, which is synthesized primarily in the...
Studies of animal models have...
07/23/2012
First Report Managed Care
News
Integrated Genetic Profiling in Acute Myeloid Leukemia
07/23/2012
Kevin L. Carter
A series of somatic mutations that affect the progression and development of acute myeloid leukemia (AML) has recently been discovered. The prognostic relevance of cytogenetic abnormalities has led to the widespread adoption of risk...
A series of somatic mutations that affect the progression and development of acute myeloid leukemia (AML) has recently been discovered. The prognostic relevance of cytogenetic abnormalities has led to the widespread adoption of risk...
A series of somatic mutations...
07/23/2012
First Report Managed Care
Bosutinib versus Imatinib in Treating Chronic Myeloid Leukemia
07/23/2012
Tim Casey
Chicago—After 30 months, patients with Philadelphia chromosome-positive chronic phase chronic myeloid leukemia who took bosutinib had superior efficacy and safety results compared with those who received imatinib, according to updated...
Chicago—After 30 months, patients with Philadelphia chromosome-positive chronic phase chronic myeloid leukemia who took bosutinib had superior efficacy and safety results compared with those who received imatinib, according to updated...
Chicago—After 30 months,...
07/23/2012
First Report Managed Care
Continuous Therapy in Prostate Cancer Patients
07/23/2012
Tim Casey
Chicago—A phase 3, international, randomized trial of patients with hormone-sensitive metastatic prostate cancer found that overall survival was inferior in those who had intermittent androgen deprivation therapy compared with those who...
Chicago—A phase 3, international, randomized trial of patients with hormone-sensitive metastatic prostate cancer found that overall survival was inferior in those who had intermittent androgen deprivation therapy compared with those who...
Chicago—A phase 3,...
07/23/2012
First Report Managed Care
Orteronel to Treat Nonmetastatic Castration-Resistant Prostate Cancer
07/23/2012
Tim Casey
Chicago—An analysis of an ongoing phase 2 study found that patients with nonmetastatic, castration-resistant prostate cancer (nmCRPC) and rising prostate-specific antigen (PSA) reacted well to and managed toxicities when taking orteronel, an...
Chicago—An analysis of an ongoing phase 2 study found that patients with nonmetastatic, castration-resistant prostate cancer (nmCRPC) and rising prostate-specific antigen (PSA) reacted well to and managed toxicities when taking orteronel, an...
Chicago—An analysis of an...
07/23/2012
First Report Managed Care
T-DM1 Superior to Capecitabine plus Lapatinib in Advanced Breast Cancer
07/23/2012
Tim Casey
Chicago—The first phase 3 study to evaluate trastuzumab emtansine (T-DM1) in patients with HER2-positive metastatic breast cancer found that the investigational antibody drug conjugate had superior efficacy and safety compared with an...
Chicago—The first phase 3 study to evaluate trastuzumab emtansine (T-DM1) in patients with HER2-positive metastatic breast cancer found that the investigational antibody drug conjugate had superior efficacy and safety compared with an...
Chicago—The first phase 3 study...
07/23/2012
First Report Managed Care
Nab-Paclitaxel, Ixabepilone Not Superior to Paclitaxel
07/23/2012
Tim Casey
Chicago—A phase 3 study found that nab-paclitaxel and ixabepilone were not superior to standard treatment (paclitaxel) in patients with chemotherapy-naïve metastatic breast cancer who also received bevacizumab. Hope S. Rugo, MD, professor of...
Chicago—A phase 3 study found that nab-paclitaxel and ixabepilone were not superior to standard treatment (paclitaxel) in patients with chemotherapy-naïve metastatic breast cancer who also received bevacizumab. Hope S. Rugo, MD, professor of...
Chicago—A phase 3 study found...
07/23/2012
First Report Managed Care
Afatinib Effective in Treating Late-Stage NSCLC
07/23/2012
Tim Casey
Chicago—Patients with advanced stage non–small cell lung cancer (NSCLC) who took the investigational oral agent afatinib had a significantly longer progression-free survival compared with those who received a standard combination chemotherapy...
Chicago—Patients with advanced stage non–small cell lung cancer (NSCLC) who took the investigational oral agent afatinib had a significantly longer progression-free survival compared with those who received a standard combination chemotherapy...
Chicago—Patients with advanced...
07/23/2012
First Report Managed Care
Nausea and Vomiting in Cancer Patients
07/23/2012
Tim Casey
Orlando—When cancer patients undergo chemotherapy treatments, they face numerous challenges, among them nausea and vomiting. Physicians and nurses sometimes underestimate how many patients will have these side effects, according to Charles...
Orlando—When cancer patients undergo chemotherapy treatments, they face numerous challenges, among them nausea and vomiting. Physicians and nurses sometimes underestimate how many patients will have these side effects, according to Charles...
Orlando—When cancer patients...
07/23/2012
First Report Managed Care
Conference Insider
Antiplatelet Therapies and Acute Coronary Syndrome
07/23/2012
Tim Casey
Orlando—Patients with acute coronary syndromes have several options when it comes to antiplatelet therapies, including aspirin, clopidogrel, prasugrel, and glycoprotein IIb/IIIa inhibitors such as abciximab, eptifibatide, and tirofiban. The...
Orlando—Patients with acute coronary syndromes have several options when it comes to antiplatelet therapies, including aspirin, clopidogrel, prasugrel, and glycoprotein IIb/IIIa inhibitors such as abciximab, eptifibatide, and tirofiban. The...
Orlando—Patients with acute...
07/23/2012
First Report Managed Care
Kaiser Report Outlines Impact of Growing Healthcare Costs
07/23/2012
Jill Sederstorm
Healthcare-related spending continues to grow each year, making it a challenge for policymakers to find ways to ensure those costs are met, according to a new report from The Henry J. Kaiser Family Foundation. The report, titled Healthcare...
Healthcare-related spending continues to grow each year, making it a challenge for policymakers to find ways to ensure those costs are met, according to a new report from The Henry J. Kaiser Family Foundation. The report, titled Healthcare...
Healthcare-related spending...
07/23/2012
First Report Managed Care
Healthcare Reform in Massachusetts: A 6-Year Review
07/23/2012
Jill Sederstorm
A robust healthcare reform initiative in the state of Massachusetts has significantly reduced the number of uninsured residents in the state and improved patient access to healthcare services, but there are still challenges that remain. These...
A robust healthcare reform initiative in the state of Massachusetts has significantly reduced the number of uninsured residents in the state and improved patient access to healthcare services, but there are still challenges that remain. These...
A robust healthcare reform...
07/23/2012
First Report Managed Care
Medicare Part D Spending Lower than Projected
07/23/2012
Tori Socha
The centerpiece of the Medicare Modernization Act of 2003 was the Part D prescription drug benefit. The cost of the program has been approximately 30% lower than projected by the Congressional Budget Office (CBO) during the Congressional...
The centerpiece of the Medicare Modernization Act of 2003 was the Part D prescription drug benefit. The cost of the program has been approximately 30% lower than projected by the Congressional Budget Office (CBO) during the Congressional...
The centerpiece of the Medicare...
07/23/2012
First Report Managed Care
Governors’ Proposals for FY 2103 Medicaid Spending
07/23/2012
Tori Socha
As states look forward to FY 2013, economic conditions have, on the whole, shown improvement.
As states look forward to FY 2013, economic conditions have, on the whole, shown improvement.
As states look forward to FY...
07/23/2012
First Report Managed Care
Healthcare Costs Associated with Neonatal Abstinence Syndrome
07/23/2012
Tori Socha
Recent data indicate that 16.2% of pregnant teens and 7.4% of pregnant women 18 to 25 years of age use illicit drugs.
Recent data indicate that 16.2% of pregnant teens and 7.4% of pregnant women 18 to 25 years of age use illicit drugs.
Recent data indicate that 16.2%...
07/23/2012
First Report Managed Care
Metformin and Rosiglitazone in Youth with Type 2 Diabetes
07/23/2012
Jill Sederstorm
A study of youth with type 2 diabetes found that combination treatment with metformin and rosiglitazone was superior to metformin alone in providing durable glycemic control. The results of the TODAY (Treatment Options for Type 2 Diabetes in...
A study of youth with type 2 diabetes found that combination treatment with metformin and rosiglitazone was superior to metformin alone in providing durable glycemic control. The results of the TODAY (Treatment Options for Type 2 Diabetes in...
A study of youth with type 2...
07/23/2012
First Report Managed Care
Brachytherapy after Lumpectomy in Older Women with Breast Cancer
07/23/2012
Mary Beth Nierengarten
Results of a retrospective population-based cohort study [JAMA. 2012;307(17):1827-1837] show that older women with breast cancer treated with brachytherapy compared with whole-breast irradiation (WBI) have worse outcomes in terms of less...
Results of a retrospective population-based cohort study [JAMA. 2012;307(17):1827-1837] show that older women with breast cancer treated with brachytherapy compared with whole-breast irradiation (WBI) have worse outcomes in terms of less...
Results of a retrospective...
07/23/2012
First Report Managed Care
Autologous BMCs for Patients with Chronic Ischemic Heart Failure
07/23/2012
Jill Sederstorm
A randomized study of patients with chronic ischemic heart failure revealed that patients who received transendocardial injections of autologous bone marrow mononuclear cells (BMCs) did not demonstrate improved left ventricular end-systolic...
A randomized study of patients with chronic ischemic heart failure revealed that patients who received transendocardial injections of autologous bone marrow mononuclear cells (BMCs) did not demonstrate improved left ventricular end-systolic...
A randomized study of patients...
07/23/2012
First Report Managed Care
MEPS Brief: Obesity in America
07/23/2012
Tori Socha
Obesity is a serious condition that is associated with numerous comorbid conditions, including heart disease, bone and joint problems, diabetes, and elevated cholesterol levels. The 2009 Medical Expenditure Panel Survey (MEPS) includes data...
Obesity is a serious condition that is associated with numerous comorbid conditions, including heart disease, bone and joint problems, diabetes, and elevated cholesterol levels. The 2009 Medical Expenditure Panel Survey (MEPS) includes data...
Obesity is a serious condition...
07/23/2012
First Report Managed Care
News
Laquinimod Slows Disability Progression of Relapsing-Remitting Multiple Sclerosis
07/23/2012
Mary Mihalovic
Laquinimod, an oral quinolone-3-carboxamide, was shown to slow the progression of disability and reduce rates of relapse in patients with relapsing-remitting multiple sclerosis (RRMS), according to results of a recent phase 3 study [N Engl J...
Laquinimod, an oral quinolone-3-carboxamide, was shown to slow the progression of disability and reduce rates of relapse in patients with relapsing-remitting multiple sclerosis (RRMS), according to results of a recent phase 3 study [N Engl J...
Laquinimod, an oral...
07/23/2012
First Report Managed Care
Opioid Use and Mental Health among Veterans of Iraq and Afghanistan
07/23/2012
Kevin L. Carter
According to the Department of Veterans Affairs, PTSD is the most prevalent mental health disorder among veterans of these conflicts who use VA healthcare benefits.
According to the Department of Veterans Affairs, PTSD is the most prevalent mental health disorder among veterans of these conflicts who use VA healthcare benefits.
According to the Department of...
07/23/2012
Veterans Health Today
Transcatheter Aortic-Valve Replacement Reduces Death and Hospitalization
07/23/2012
Jill Sederstorm
Transcatheter aortic-valve replacement (TAVR) was found to reduce rates of death and hospitalization in patients with severe aortic stenosis who were not suitable candidates for surgery after 2 years of follow-up when compared with patients...
Transcatheter aortic-valve replacement (TAVR) was found to reduce rates of death and hospitalization in patients with severe aortic stenosis who were not suitable candidates for surgery after 2 years of follow-up when compared with patients...
Transcatheter aortic-valve...
07/23/2012
First Report Managed Care
Cost Sharing and Asthma Medication Use in Children
07/23/2012
Tori Socha
Containing medication costs by shifting costs to patients is a strategy being increasingly utilized used by private health insurance plans. Studies have shown that when patients bear a greater proportion of medication costs, medication...
Containing medication costs by shifting costs to patients is a strategy being increasingly utilized used by private health insurance plans. Studies have shown that when patients bear a greater proportion of medication costs, medication...
Containing medication costs by...
07/23/2012
First Report Managed Care
30-Day Outcomes of Off-Pump and On-Pump CABG
07/23/2012
Tori Socha
For patients with extensive coronary artery disease, mortality can be reduced through coronary-artery bypass grafting (CABG), a procedure generally performed using cardiopulmonary bypass (on-pump). Use of the on-pump approach results in...
For patients with extensive coronary artery disease, mortality can be reduced through coronary-artery bypass grafting (CABG), a procedure generally performed using cardiopulmonary bypass (on-pump). Use of the on-pump approach results in...
For patients with extensive...
07/23/2012
First Report Managed Care
Tenecteplase vs Alteplase for Acute Ischemic Stroke
07/23/2012
Kevin L. Carter
Although thrombolytic treatment with alteplase, a recombinant tissue plasminogen activator, is the accepted therapy for ischemic stroke, alteplase has been proven to be far from ideal. Tenecteplase, a genetically engineered mutant tissue...
Although thrombolytic treatment with alteplase, a recombinant tissue plasminogen activator, is the accepted therapy for ischemic stroke, alteplase has been proven to be far from ideal. Tenecteplase, a genetically engineered mutant tissue...
Although thrombolytic treatment...
07/23/2012
First Report Managed Care
Attention to Cardiovascular Health Metrics Reduces CVD
07/23/2012
Kristina Woodworth
An analysis of data from the National Health and Nutrition Examination Survey (NHANES) has concluded that smoking, blood pressure, blood glucose level, diet, and physical activity are all closely linked with all-cause, cardiovascular disease...
An analysis of data from the National Health and Nutrition Examination Survey (NHANES) has concluded that smoking, blood pressure, blood glucose level, diet, and physical activity are all closely linked with all-cause, cardiovascular disease...
An analysis of data from the...
07/23/2012
First Report Managed Care
Epinephrine Use and Survival among OHCA Patients
07/23/2012
Kevin L. Carter
Although epinephrine is often used in cardiopulmonary resuscitation for out-of-hospital cardiac arrest, the effectiveness of use before hospital arrival is unknown.
Although epinephrine is often used in cardiopulmonary resuscitation for out-of-hospital cardiac arrest, the effectiveness of use before hospital arrival is unknown.
Although epinephrine is often...
07/23/2012
First Report Managed Care
Unnecessary Anesthesia Services for Gastrointestinal Endoscopies Increase Costs
07/23/2012
Eileen Koutnik-Fotopoulos
During a 6-year period, utilization of anesthesia services for gastroenterology procedures increased significantly, particularly in low-risk patients who may have been candidates for less expensive intravenous sedation [JAMA....
During a 6-year period, utilization of anesthesia services for gastroenterology procedures increased significantly, particularly in low-risk patients who may have been candidates for less expensive intravenous sedation [JAMA....
During a 6-year period,...
07/23/2012
First Report Managed Care
Conference Insider
Flexible Sigmoidoscopy Reduces Incidence of Colorectal Cancer
07/23/2012
Mary Mihalovic
The use of flexible sigmoidoscopy as a screening tool significantly reduced the overall mortality associated with colorectal cancer by 26% and its incidence by 21%, according to results of a recent study [N Engl J Med. 2012;...
The use of flexible sigmoidoscopy as a screening tool significantly reduced the overall mortality associated with colorectal cancer by 26% and its incidence by 21%, according to results of a recent study [N Engl J Med. 2012;...
The use of flexible...
07/23/2012
First Report Managed Care
FDA, Health Canada, and EMA Regulators Seek Collaboration
07/23/2012
Tim Casey
Like her colleagues throughout the world, Margaret Hamburg, MD, has been dealing with issues that she could have never foreseen when she became the FDA’s commissioner in May 2009. Science continues to advance rapidly, making it difficult to...
Like her colleagues throughout the world, Margaret Hamburg, MD, has been dealing with issues that she could have never foreseen when she became the FDA’s commissioner in May 2009. Science continues to advance rapidly, making it difficult to...
Like her colleagues throughout...
07/23/2012
First Report Managed Care
US Supreme Court Upholds Affordable Care Act
07/23/2012
Tim Casey
At 10:22 am EDT on June 28, 866,000 people logged onto SCOTUSblog, a website devoted to providing up-to-the minute coverage of Supreme Court decisions. Minutes earlier, the Supreme Court had upheld the constitutionality of the Patient...
At 10:22 am EDT on June 28, 866,000 people logged onto SCOTUSblog, a website devoted to providing up-to-the minute coverage of Supreme Court decisions. Minutes earlier, the Supreme Court had upheld the constitutionality of the Patient...
At 10:22 am EDT on June 28,...
07/23/2012
First Report Managed Care

Behind the Bill

Behind the Bill
The Senate’s $3 Trillion Deal. Tax Relief Now, Medicaid Coverage Loss Later?
07/02/2025
Katie Hayes, MJ
The Senate has done it. After weeks of behind-the-scenes wrangling and last-minute amendments, lawmakers have passed a sprawling tax-and-spending megabill that makes good on a long-standing Republican goal: making the 2017 Trump tax cuts...
The Senate has done it. After weeks of behind-the-scenes wrangling and last-minute amendments, lawmakers have passed a sprawling tax-and-spending megabill that makes good on a long-standing Republican goal: making the 2017 Trump tax cuts...
The Senate has done it. After...
07/02/2025
First Report Managed Care
Behind the Bill
When a Cap Isn’t Just a Cap: How a Provider Tax Proposal Could Reshape Medicaid Financing
06/25/2025
Katie Hayes, MJ
In Washington, the most consequential policies are often buried in the fine print. One such detail in the Senate Finance Committee’s latest tax and spending proposal would gradually cap provider taxes—a core funding tool states use to pull in...
In Washington, the most consequential policies are often buried in the fine print. One such detail in the Senate Finance Committee’s latest tax and spending proposal would gradually cap provider taxes—a core funding tool states use to pull in...
In Washington, the most...
06/25/2025
First Report Managed Care
Behind the Bill
Rewriting the Safety Net? Inside the Senate’s Changes to Medicaid and the ACA
06/18/2025
Katie Hayes, MJ
Over the past few weeks, I’ve been following the progress of the One Big Beautiful Bill Act (OBBBA), which started in the House with sweeping tax reforms and some eye-catching health care proposals. Now, the Senate has released its (highly...
Over the past few weeks, I’ve been following the progress of the One Big Beautiful Bill Act (OBBBA), which started in the House with sweeping tax reforms and some eye-catching health care proposals. Now, the Senate has released its (highly...
Over the past few weeks, I’ve...
06/18/2025
First Report Managed Care
Behind the Bill
How States Might Respond to the One Big Beautiful Bill Act
06/11/2025
Katie Hayes, MJ
With the One Big Beautiful Bill Act (OBBBA) still in the hands of the Senate, much of the national conversation has centered on what this legislation would do to federal coverage programs. But regardless of how the federal process unfolds,...
With the One Big Beautiful Bill Act (OBBBA) still in the hands of the Senate, much of the national conversation has centered on what this legislation would do to federal coverage programs. But regardless of how the federal process unfolds,...
With the One Big Beautiful Bill...
06/11/2025
First Report Managed Care
Behind the Bill
Is the Affordable Care Act on the Chopping Block? What the One Big Beautiful Bill Act Tells Us.
06/04/2025
Katie Hayes, MJ
It’s been weeks of headline-grabbing debate over Medicaid work requirements, and the “One Big Beautiful Bill Act” remains in the Senate as they deliberate over several health care provisions. While the Medicaid provisions sparked most of the...
It’s been weeks of headline-grabbing debate over Medicaid work requirements, and the “One Big Beautiful Bill Act” remains in the Senate as they deliberate over several health care provisions. While the Medicaid provisions sparked most of the...
It’s been weeks of...
06/04/2025
First Report Managed Care
Behind the Bill
From House to Senate: The Journey of Cutting Medicaid
05/28/2025
Katie Hayes, MJ
Last week, the House of Representatives narrowly passed the One Big Beautiful Bill Act (HR 1, 119th Congress) by a single vote, sending the sweeping tax and spending reconciliation package, backed by President Trump, to the Senate. With its...
Last week, the House of Representatives narrowly passed the One Big Beautiful Bill Act (HR 1, 119th Congress) by a single vote, sending the sweeping tax and spending reconciliation package, backed by President Trump, to the Senate. With its...
Last week, the House of...
05/28/2025
First Report Managed Care
Behind the Bill
Eligibility, Paperwork, and Penalties: The Not-So-Hidden Costs of Medicaid ‘Reform’
05/21/2025
Katie Hayes, MJ
It’s been another eventful week in health policy—a phrase that’s quickly becoming routine. This time, House Republicans advanced a sweeping budget reconciliation bill, designed to implement elements of the March budget resolution, with a...
It’s been another eventful week in health policy—a phrase that’s quickly becoming routine. This time, House Republicans advanced a sweeping budget reconciliation bill, designed to implement elements of the March budget resolution, with a...
It’s been another eventful week...
05/21/2025
First Report Managed Care
Behind the Bill
A Busy Week in Drug Pricing Policy: Aligning US Drug Prices With Global Standards?
05/14/2025
Katie Hayes, MJ
It’s been a busy few days for drug pricing policy. While I’d love to dig into the details of both President Trump’s latest executive order and the newest Republican bill that would cut Medicaid spending, we don’t have the time—and this isn’t...
It’s been a busy few days for drug pricing policy. While I’d love to dig into the details of both President Trump’s latest executive order and the newest Republican bill that would cut Medicaid spending, we don’t have the time—and this isn’t...
It’s been a busy few days for...
05/14/2025
First Report Managed Care
BEHIND THE BILL
When Agencies Lose Power: How 3 Seismic Shifts are Transforming Pharmaceutical Regulation
05/07/2025
Katie Hayes, MJ
In the span of just 9 months, the landscape of administrative law has undergone a transformation so profound that pharmaceutical executives, health care providers, and patients alike are struggling to navigate the new terrain. The Supreme...
In the span of just 9 months, the landscape of administrative law has undergone a transformation so profound that pharmaceutical executives, health care providers, and patients alike are struggling to navigate the new terrain. The Supreme...
In the span of just 9 months,...
05/07/2025
First Report Managed Care
Behind the Bill
The Medicare Paradox, Part 3: Strategic Trade Doesn’t Have to be a Zero-Sum Game
05/07/2025
Katie Hayes, MJ
Over the past 2 weeks, I’ve examined the growing friction between the Section 232 pharmaceutical tariff investigations and the Medicare drug pricing reforms authorized by the Inflation Reduction Act (IRA). These 2 policy agendas—industrial...
Over the past 2 weeks, I’ve examined the growing friction between the Section 232 pharmaceutical tariff investigations and the Medicare drug pricing reforms authorized by the Inflation Reduction Act (IRA). These 2 policy agendas—industrial...
Over the past 2 weeks, I’ve...
05/07/2025
First Report Managed Care

Trending Articles

News
Comparative Effectiveness for Bronchodilator Responsiveness Testing
02/09/2024
Emry Lloyd
A new study compares the efficacy of salbutamol administration via a nebulizer vs a metered-dose inhaler with a spacer for bronchodilator responsiveness testing.
A new study compares the efficacy of salbutamol administration via a nebulizer vs a metered-dose inhaler with a spacer for bronchodilator responsiveness testing.
A new study compares the...
02/09/2024
First Report Managed Care
News
Trial to Test CAR T-Cell Therapy for Refractory Progressive MS
03/18/2024
Jolynn Tumolo
An autologous, fully human CD19 chimeric antigen receptor (CAR) T-cell product candidate recently received clearance from the US Food and Drug Administration (FDA) as an investigational new drug for the treatment of patients with refractory...
An autologous, fully human CD19 chimeric antigen receptor (CAR) T-cell product candidate recently received clearance from the US Food and Drug Administration (FDA) as an investigational new drug for the treatment of patients with refractory...
An autologous, fully human CD19...
03/18/2024
First Report Managed Care
Conference Coverage
PBM Legislation: Navigating Congressional Delays and Encouraging Progress
04/17/2024
Hannah Musick
Explore the world of federal pharmacy benefit manager (PBM) legislation and its potential impact on stakeholders in this in-depth analysis presented by Ross Margulies, JD, MPH, Partner and Co-Chair Healthcare and Life Sciences Coverage &...
Explore the world of federal pharmacy benefit manager (PBM) legislation and its potential impact on stakeholders in this in-depth analysis presented by Ross Margulies, JD, MPH, Partner and Co-Chair Healthcare and Life Sciences Coverage &...
Explore the world of federal...
04/17/2024
First Report Managed Care
Conference Coverage
The Impact of Fatigue on Prospective Memory in Persons With MS
05/23/2024
Hannah Musick
High fatigue levels in persons with multiple sclerosis (MS) are significantly associated with subjective impairment in prospective memory, particularly in tasks such as forgetting the date and missing appointments.
High fatigue levels in persons with multiple sclerosis (MS) are significantly associated with subjective impairment in prospective memory, particularly in tasks such as forgetting the date and missing appointments.
High fatigue levels in persons...
05/23/2024
First Report Managed Care
Interview
Enhancing Patient Services: Payer and Provider Considerations
06/28/2024
Patient services emerged as a central topic at AXS24, with many stakeholders emphasizing the need for consistency and accessibility in patient support. They also highlighted the importance of addressing both financial and emotional support...
Patient services emerged as a central topic at AXS24, with many stakeholders emphasizing the need for consistency and accessibility in patient support. They also highlighted the importance of addressing both financial and emotional support...
Patient services emerged as a...
06/28/2024
First Report Managed Care

July 2012 Volume 9 Issue 7

View Issue Archive
Editorial Correspondence

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use